These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 10729129)

  • 41. HIV-1 Cell-Free and Cell-to-Cell Infections Are Differentially Regulated by Distinct Determinants in the Env gp41 Cytoplasmic Tail.
    Durham ND; Chen BK
    J Virol; 2015 Sep; 89(18):9324-37. PubMed ID: 26136566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Interplay between HIV-1 Gag Binding to the Plasma Membrane and Env Incorporation.
    Murphy RE; Saad JS
    Viruses; 2020 May; 12(5):. PubMed ID: 32429351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M; Lemay G; Cohen EA
    Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Conserved Tryptophan in the Envelope Cytoplasmic Tail Regulates HIV-1 Assembly and Spread.
    Snetkov X; Haider T; Mesner D; Groves N; van Engelenburg SB; Jolly C
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Susceptibility to virus-cell fusion at the plasma membrane is reduced through expression of HIV gp41 cytoplasmic domains.
    Malinowsky K; Luksza J; Dittmar MT
    Virology; 2008 Jun; 376(1):69-78. PubMed ID: 18400243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.
    Müller B; Daecke J; Fackler OT; Dittmar MT; Zentgraf H; Kräusslich HG
    J Virol; 2004 Oct; 78(19):10803-13. PubMed ID: 15367647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production.
    Freed EO; Orenstein JM; Buckler-White AJ; Martin MA
    J Virol; 1994 Aug; 68(8):5311-20. PubMed ID: 8035531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutations in the leucine zipper-like heptad repeat sequence of human immunodeficiency virus type 1 gp41 dominantly interfere with wild-type virus infectivity.
    Chen SS; Lee SF; Hao HJ; Chuang CK
    J Virol; 1998 Jun; 72(6):4765-74. PubMed ID: 9573241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutations of conserved glycine residues within the membrane-spanning domain of human immunodeficiency virus type 1 gp41 can inhibit membrane fusion and incorporation of Env onto virions.
    Miyauchi K; Curran R; Matthews E; Komano J; Hoshino T; Engelman DM; Matsuda Z
    Jpn J Infect Dis; 2006 Apr; 59(2):77-84. PubMed ID: 16632906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein.
    Cimarelli A; Luban J
    J Virol; 1999 Jul; 73(7):5388-401. PubMed ID: 10364286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modification of virus infectivity by cytoplasmic tail of HIV-1 TM protein.
    Iwatani Y; Ueno T; Nishimura A; Zhang X; Hattori T; Ishimoto A; Ito M; Sakai H
    Virus Res; 2001 Apr; 74(1-2):75-87. PubMed ID: 11226576
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human immunodeficiency virus type 1 and 2 envelope glycoproteins oligomerize through conserved sequences.
    Center RJ; Kemp BE; Poumbourios P
    J Virol; 1997 Jul; 71(7):5706-11. PubMed ID: 9188654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutational analysis of conserved domains within the cytoplasmic tail of gp41 from human immunodeficiency virus type 1: effects on glycoprotein incorporation and infectivity.
    Piller SC; Dubay JW; Derdeyn CA; Hunter E
    J Virol; 2000 Dec; 74(24):11717-23. PubMed ID: 11090171
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins.
    Gabuzda DH; Lever A; Terwilliger E; Sodroski J
    J Virol; 1992 Jun; 66(6):3306-15. PubMed ID: 1583717
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation.
    West JT; Weldon SK; Wyss S; Lin X; Yu Q; Thali M; Hunter E
    J Virol; 2002 Apr; 76(7):3338-49. PubMed ID: 11884559
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
    Affranchino JL; González SA
    Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner.
    Demirov DG; Orenstein JM; Freed EO
    J Virol; 2002 Jan; 76(1):105-17. PubMed ID: 11739676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission.
    Santos da Silva E; Mulinge M; Lemaire M; Masquelier C; Beraud C; Rybicki A; Servais JY; Iserentant G; Schmit JC; Seguin-Devaux C; Perez Bercoff D
    PLoS One; 2016; 11(9):e0161596. PubMed ID: 27598717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6(Gag) protein produces a mutant that fails to package its envelope protein.
    Ott DE; Chertova EN; Busch LK; Coren LV; Gagliardi TD; Johnson DG
    J Virol; 1999 Jan; 73(1):19-28. PubMed ID: 9847302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease.
    Waheed AA; Ablan SD; Roser JD; Sowder RC; Schaffner CP; Chertova E; Freed EO
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8467-71. PubMed ID: 17483482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.